Behrenbruch Christian - 18 Mar 2026 Form 3 Insider Report for Telix Pharmaceuticals Ltd (TLX)

Role
MD & Group CEO, Director
Signature
/s/ Genevieve Ryan, on behalf of Dr. Christian Behrenbruch, MD & Group CEO
Issuer symbol
TLX
Transactions as of
18 Mar 2026
Net transactions value
$0
Form type
3
Filing time
18 Mar 2026, 20:45:57 UTC
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Behrenbruch Christian MD & Group CEO, Director C/O TELIX PHARMACEUTICALS LTD, 55 FLEMINGTON RD, NORTH MELBOURNE, AUSTRALIA /s/ Genevieve Ryan, on behalf of Dr. Christian Behrenbruch, MD & Group CEO 18 Mar 2026 0002037713

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding TLX Ordinary Shares 20,675,000 18 Mar 2026 Elk River Holdings Pty Ltd F1
holding TLX American Depositary Receipts 400,000 18 Mar 2026 Direct F2
holding TLX Ordinary Shares 254,006 18 Mar 2026 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding TLX Performance Share Appreciation Rights (right to buy) 18 Mar 2026 Ordinary Shares 93,114 $4.95 Direct F3, F4
holding TLX Performance Share Appreciation Rights (right to buy) 18 Mar 2026 Ordinary Shares 100,223 $6.90 Direct F4, F5
holding TLX Share Rights 18 Mar 2026 Ordinary Shares 2,595 $0.000000 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Dr. Behrenbruch is the sole director and shareholder of Elk River Holdings Pty Ltd.
F2 Each American Depositary Receipt (ADR) is convertible at any time, at the holders election, into one ordinary share of the issuer. The ADRs have no expiration date.
F3 The performance share appreciation rights (PSARs) were granted on April 5, 2022 and became vested and exercisable on March 6, 2025.
F4 Conversion price is reported in Australian Dollars.
F5 The PSARs were granted on May 30, 2023, and became vested and exercisable on March 12, 2026.
F6 The share rights were granted on May 21, 2025, and became vested and exercisable on March 5, 2026.

Remarks:

Ex. 24 - Power of Attorney